• 고려인삼학회:학술대회논문집
• /
• 고려인삼학회 1988년도 학술대회지
• /
• pp.63-69
• /
• 1988

Streptozotocin으로 유발시킨 당뇨병성 쥐(혈당수준$430{\pm}30ml/dl$)에게 ginsenoside-$Rb_{2}$를 연속적으로 복강투여 하였다. Ginsenoside $Rb_{2}$ 투여군은 현저한 혈당감소를 보였으며 이군들의 혈당수준은 6-9일 투여로 약 160mg/dl로 떨어졌다. 한편 대조군보다 먹이섭취량이 적지만 체중은 ginsenoside-$Rb_{2}$를 투여한 당뇨쥐에서 상당히 증가하였다. Ginsenoside-$Rb_{2}$투여군은 과식, 다뇨, 당뇨 등과 같은 당뇨병 증상이 개선 되었다. 혈당을 떨어뜨리는 작용기전을 연구하기위한 일환으로 간 및 지방조직 그리고 혈청 등에 있는 탄수화물 대사물질과 지질성분 등에 미치는 ginsenoside-$Rb_{2}$의 효과를 조사하였다. 당뇨쥐에서는 ginsenoside-$Rb_{2}$가 먼저 정상쥐에서와 같이 간에서 혈당의 이용을 촉진 시키고 그결과 지방조직에 triglyceride 들이 증가되는 것으로 추측된다.

• Journal of Ginseng Research
• /
• 제28권2호
• /
• pp.87-93
• /
• 2004

인삼성분 중 ginsenoside-Rb$_2$에 의한 LDL receptor발현 증가의 기전을 HepG$_2$세포에서 관찰하였고 이를 lovastatin과 비교하였다. 콜레스테롤 투여에 의하여 억제된 LDL receptor mRNA발현이 ginsenoside-Rb$_2$에 의하여 다시 증가하였고 이는 lovastatin에 의한 증가 효과보다 뛰어났다. SREBP mRNA의 발현 또한 콜레스테롤 투여에 의하여 억제되나 ginseonside-Rb$_2$에 의하여 발현이 증가하였고 이는 lovastatin에 의한 효과와 비슷하였다. 세포에 투여한 ginsenoside-Rb$_2$의 농도에 비례하여 SREBP-1 mRNA의 발현이 증가하였으며 ginsenoside-Rb$_2$의 대사체인 compound K를 투여한 경우에도 SREBP-1 mRNA가 비슷한 양상으로 혹은 더 많이 발현되었다. 따라서 ginsenoside-Rb$_2$에 의한 LDL receptor의 발현 증가는 SREBP의 발현 증가 때문이라고 설명할 수 있다. 즉 ginsenoside-Rb$_2$에 의한 SREBP 발현 증가는 콜레스테롤 투여에 의하여 억제된 LDL receptor발현을 증가시켜 결과적으로 혈중의 콜레스테롤을 효과적으로 제거하는 것으로 판단된다.

• 한국미생물·생명공학회지
• /
• 제10권4호
• /
• pp.267-273
• /
• 1982

미생물성 효소를 이용하여 인삼saponin중 조성비율이 가장 큰 ginsenoside-Rb$_1$을 약효면에서 보다 우수한 ginsenoside-Rd로 전환하고자 인삼부패균 중 Rhizopus 속의 한 균주를 선정하여 이 균주에서 얻은 효소를 ammonium sulfate 분별 침전법으로 조정제하여 사용하였다. 기질로 사용하기 위해 홍미삼 extract로부터 ginsenoside-Rb$_1$이 36.4%, ginsenoside-Rd 가 12.2%의 조성비율을 갖인 total saponin을 정제하였고 이어 ginsenoside-Rb$_1$의 함량을 증가시키기 위해 더욱 정제한 결과 ginsenoside-Rb$_1$이 54. 5%, ginsenoside-Rd가 1.1%인 ginsenoside Rb group saponin을 얻었다. 이들 기질 saponin에 본 효소를 작용시켜 본 결과 두 기질 모두 다른 ginsenoside pattern에는 변화없이 ginsenoside-Rb$_1$만이 선택적으로 감소하고 반면에 ginsenoside-Rd의 함량이 비례적으로 증가됨을 TLC 및 HPLC의 방법으로 조사하였으며 이로써 효소에 의한 인삼saponin의 선택적전환 가능성을 확인하였다.

• Journal of Ginseng Research
• /
• 제37권1호
• /
• pp.80-86
• /
• 2013

Korean red ginseng has been shown to possess a variety of biological activities. However, little is known about antiviral activity of ginsenosides of Korean red ginseng. Here, we investigated the protective effect by oral administration of various ginsenosides on the lethal infection of haemagglutinating virus of Japan (HVJ) in mice. In a lethal infection model in which almost all mice infected with HVJ died within 15 days, the mice were administered orally (per os) with 1 mg/mouse of dammarane-type (ginsenoside-Rb1, -Rb2, -Rd, -Re, and -Rg2) or oleanolic acid-type (ginsenoside-Ro) ginsenosides 3, 2, and 1 d before virus infection. Ginsenoside-Rb2 showed the highest protective activity, although other dammarane-type and oleanolic acid-type ginsenosides also induced a significant protection against HVJ. However, neither the consecutive administration with a lower dosage (300 ${\mu}g$/mouse) nor the single administration of ginsenoside-Rb2 (1 mg/mouse) was active. In comparison of the protective activity between ginsenoside-Rb2 and its two hydrolytic products [20(S)- and 20(R)-ginsenoside-Rg3], 20(S)-ginsenoside-Rg3, but not 20(R)-ginsenoside-Rg3, elicited a partial protection against HVJ. The protective effect of ginsenoside-Rb2 and 20(S)-ginsenoside-Rg3 on HVJ infection was confirmed by the reduction of virus titers in the lungs of HVJ-infected mice. These results suggest that ginsenoside-Rb2 is the most effective among ginsenosides from red ginseng to prevent the lethal infection of HVJ, so that this ginsenoside is a promising candidate as a mucosal immunoadjuvant to enhance antiviral activity.

• Journal of Ginseng Research
• /
• 제24권3호
• /
• pp.134-137
• /
• 2000

Spontaneous bursting activity was studied in rat thalamocortical slices using extracellular field potential recording to test the potential utilization of ginsenoside Rb$_1$ in controlling overactivated neural systems. In order to induce bursting activity, slices were perfused with Mg$\^$2+/-free artificial cerebrospinal fluid (ACSF). Two major types of spontaneous bursting activity, simple thalamocortical burst complexes (sTBCs) and complex thalamocortical burst complexes (cTBCs), were recorded in Mg$\^$2+/ -free ACSF. Ginsenoside Rb$_1$ selectively suppressed cTBCs. Duration and occurrence rate of cTBCs were reduced by 87.3${\pm}$10.2% and 85.3${\pm}$ 14.7% in the presence of 90 ${\mu}$M ginsenoside Rb$_1$ respectively, while amplitude and intraburst frequency were slightly changed by ginsenoside Rb$_1$. In contrast, ginsenoside Rb$_1$was much less effective in reducing duration and occurrence rate of sTBCs. We also tested effects of ginsenoside Rb$_1$ on bursting activity in the presence of a GABA$\sub$A/ receptor antagonist, bicuculline methiodide (BMI). Ginsenoside Rb$_1$ had no effect in suppressing BMI-induced bursting activities. These results suggest that ginsenoside Rbi may be useful in controlling seizure-like bursting activity under pathological conditions.

• Journal of Microbiology and Biotechnology
• /
• 제28권3호
• /
• pp.391-396
• /
• 2018

It is well known that Korean red ginseng has various biological activities. However, there is little knowledge about the antiviral activity of Korean red ginseng and its ginsenosides. In this study, we addressed whether oral administration of ginsenoside-Rb2 and -Rg3 is able to protect against rotavirus (RV) infection. The protective effect of ginsenosides against RV infection was examined using an in vivo experiment model in which newborn mice (10-day-old) were inoculated perorally (p.o.) with $1.5{\times}10^6$ plaque-forming units/mouse of RV strain SA11. When various dosages of ginsenoside-Rb2 (25-250 mg/kg) were administered 3days, 2 days, or 1 day before virus challenge, treatment with this ginsenoside at the dosage of 75 mg/kg 3days before virus infection most effectively reduced RV-induced diarrhea. In addition, consecutive administration of ginsenoside-Rb2 (75 mg/kg) at 3 days, 2 days, and 1 day before virus infection was more effective than single administration on day -3. The consecutive administration of ginsenoside-Rb2 also reduced virus titers in the bowels of RV-infected mice. In an experiment to compare the protective activity between ginsenoside-Rb2 and its two hydrolytic products (20(S)- and 20(R)-ginsenoside-Rg3), 20(S)-ginsenoside-Rg3, but not 20(R)-ginsenoside-Rg3, prevented RV infection. These results suggest that ginsenoside-Rb2 and its hydrolytic product, 20(S)-ginsenoside-Rg3, are promising candidates as an antiviral agent to protect against RV infection.

• Journal of Ginseng Research
• /
• 제14권2호
• /
• pp.112-116
• /
• 1990

As a part of studies on the quality control of crude drug preparation drinks, ginseng saponins were identified by HPLC. Ginsenoside-Rb1 was determined quantitatively by HPLC. Ginsenoside MeOH/H2O(65:35:10, v/v) on Si-gel plate. Ginsenoside-Rb1 content determined by HPLC on Lichrosorbtract drinks was 57.5-70.4% compared to the content in the red ginseng extract.

• Journal of Ginseng Research
• /
• 제40권2호
• /
• pp.105-112
• /
• 2016

Background: Minor saponins or human intestinal bacterial metabolites, such as ginsenosides Rg3, F2, Rh2, and compound K, are more pharmacologically active than major saponins, such as ginsenosides Rb1, Rb2, and Rc. In this work, enzymatic hydrolysis of ginsenoside Rb1 was studied using enzyme preparations from cultured mycelia of mushrooms. Methods: Mycelia of Armillaria mellea, Ganoderma lucidum, Phellinus linteus, Elfvingia applanata, and Pleurotus ostreatus were cultivated in liquid media at $25^{\circ}C$ for 2 wk. Enzyme preparations from cultured mycelia of five mushrooms were obtained by mycelia separation from cultured broth, enzyme extraction, ammonium sulfate (30-80%) precipitation, dialysis, and freeze drying, respectively. The enzyme preparations were used for enzymatic hydrolysis of ginsenoside Rb1. Results: Among the mushrooms used in this study, the enzyme preparation from cultured mycelia of A. mellea (AMMEP) was found to convert ginsenoside Rb1 into compound K with a high yield, while those from G. lucidum, P. linteus, E. applanata, and P. ostreatus produced remarkable amounts of ginsenoside Rd from ginsenoside Rb1. The enzymatic hydrolysis pathway of ginsenoside Rb1 by AMMEP was $Rb1{\rightarrow}Rd{\rightarrow}F2{\rightarrow}$ compound K. The optimum reaction conditions for compound K formation from ginsenoside Rb1 were as follows: reaction time 72-96 h, pH 4.0-4.5, and temperature $45-55^{\circ}C$. Conclusion: AMMEP can be used to produce the human intestinal bacterial metabolite, compound K, from ginsenoside Rb1 with a high yield and without food safety issues.

• Archives of Pharmacal Research
• /
• 제25권1호
• /
• pp.71-76
• /
• 2002

Ginseng has been used as a traditional medicine with various therapeutic effects. However, it is still unknown which component of this plant is effective at promoting wound healing. Recently, ginsenoside $Rb_2$ has been reported to improve wound healing. In this study, to investigate the reported wound healing effect of the ginsenoside $Rb_2$, cell morphology and protein factors involved in epidermal formation were evaluated by immunshemical and immunoblotting analysis. $Rb_2$ stimulated epidermal cell proliferation, and the cell showed a 1.5-fold increase in thymidine uptake compared to the control (p<0.05, n=3). Futheremore $Rb_2$, was found to stimulate epidermis formation in a dose-dependent manner in raft culture, and to dose dependently enhance the expressions of protein factors related to cell proliferation, namely, epidermal growth factor and its receptor, fibronectin and its receptor, keratin 5/14, and collagenase 1 (p<0.05, n=3~9). It is believed that ginsenoside $Rb_2$, enhances epidermal cell proliferation by upregulating the expressions of these proliferation-related factors.

• 대한약침학회지
• /
• 제13권1호
• /
• pp.63-77
• /
• 2010

Objectives: The aim of this experiment is to provide an objective differentiation of cultivated ginseng, cultivated wild ginseng, and wild ginseng through component analysis, and to know the change of ginsenoside components in the process for making red ginseng. Methods: Comparative analysis of ginsenoside $Rb_1,\;Rb_2$, Rc, Rd, Re, Rf, $Rg_1,\;Rg_3,\;Rh_1$ and $Rh_2$ from the cultivated ginseng 4 and 6 years, cultivated wild ginseng, and wild ginseng were conducted using High Performance Liquid Chromatography(hereafter HPLC). And the same analyses were conducted in the process of red ginseng. Results: 1. For content comparison of ginsenoside $Rb_1$, Rc, Rd, Rf, $Rg_1$ and $Rh_1$, wild ginseng showed high content, followed cultivated ginseng 4 and 6 years, cultivated wild ginseng showed low content than any other samples. 2. For content comparison of ginsenoside $Rb_2$ and Re, cultivated ginseng 4 years showed high content, followed wild ginseng and cultivated ginseng 6 years, cultivated wild ginseng showed low content than any other samples. 3. For content comparison of ginsenoside $Rg_3$, wild ginseng and cultivated wild ginseng were only showed low content. 4. For content comparison of ginsenoside $Rh_2$, cultivated wild ginseng was only showed low content. 5. In the process of red ginseng, ginsenoside $Rb_1,\;Rb_2$, Rc, Rd, $Rg_3$ and $Rh_1$ were increased, and ginsenoside Re and $Rg_1$ were decreased in cultivated wild ginseng. 6. In the process of red ginseng, ginsenoside $Rg_3$ and $Rh_1$ were increased, and ginsenoside $Rb_2$, Rc, and Re were decreased in cultivated ginseng 4 years. 7. In the process of red ginseng, ginsenoside $Rb_1,\;Rb_2$, Rf and $Rh_1$ were increased, and ginsenoside Rc and Rd were decreased in cultivated ginseng 6 years. Conclusions: Distribution of ginsenoside contents to the cultivated ginseng, cultivated wild ginseng, and wild ginseng was similar and was not showed special characteristics between samples. And the change of ginsenoside to the process of red ginseng, cultivated ginseng and cultivated wild ginseng were showed different aspect.